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We have studied metallothionein (MT) induction by three primary inducers; a heavy metal, a glucocorticoid and a cytokine, and by the combina- 
tions of these inducers in the cultured cells. MT-protein was synergistically induced by either a cytokine or a heavy metal with a glucocorticoid 
hormone and was additively induced by the combination of a cytokine and a heavy metal, but MT-mRNA levels were not completely correlated 
with MT-protein levels. These results suggest hat posttranscriptional regulation may be involved in the synergistic induction of MT-protein. We 
propose a possible mechanism in which marked MT induction by stress in vivo is dependent on the combined effect of two or more inducers, 
because marked MT induction is not seen by an injection of a plausible dose of either a glucocorticoid hormone or a cytokine in vivo. 
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1. INTRODUCTION 
Metallothionein (MT) is a low molecular weight, 
heavy metal binding protein, which is rich in cysteine 
residue and thus able to bind heavy metals including 
zinc, copper and mercury. The physiological functions 
of the protein have been reported to be detoxification of 
heavy metals, metabolism of trace metals, scavenging 
of free radicals, etc. (see [I] for review). 
MT is induced by heavy metals, glucocorticoid hor- 
mones [2], 12-0-tetradecanoylphorbol-13-acetate [3], 
cytokines such as interferon [4], interleukin 1 [5], 
epidermal growth factor (EGF) and platelet-derived 
growth factor [6], ultraviolet light [7] and la,25 
dihydroxyvitamin D3 [8] in cultured cells. In contrast, 
this protein is also induced in vivo by stresses including 
cold, heat, exercise and burn [9], mainly in the liver. 
MT is also induced in vivo by administrations of 
bacterial endotoxin [lo], turpentine [ 111, alcohol [ 121, 
carbon tetrachloride [9] and by X-ray irradiation [13], 
which are thought to be stresses. However, the 
mechanism(s) of MT induction by these stresses are not 
well known. Stress increases the circulating levels of 
glucocorticoid hormones [14], which are primary in- 
ducers of MT, but there is no direct evidence that in- 
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creased glucocorticoid hormones are mediators of MT 
induction in vivo [ 151. We have shown that transform- 
ing growth factor-a! (TGF-m) secreted by endotoxin- 
stimulated macrophages i  involved in MT induction by 
endotoxin [16]. However, we have no evidence that 
TGF-Q is the only inducer of MT by endotoxin in vivo. 
Under these circumstances, we have hypothesized 
that MT induction by stress in vivo is dependent on two 
or more inducers and, therefore, we studied the com- 
bined effects of the above primary inducers on MT in- 
duction in cultured cells. In this article, we report that 
MT-protein is inducible synergistically or additively, 
depending on the combinations of inducers and that 
posttranscriptional regulation may be involved in the 
synergistic induction of MT-protein. 
2. MATERIALS AND METHODS 
2.1. Materials 
Mouse submaxillary gland EGF (purity: >95%) was purchased 
from Takara Biochemicals (Kyoto, Japan). Dexamethasone (Dex; 
Nakarai Chemicals, Kyoto, Japan) was dissolved in 99.5% ethanol 
and added to cells in at least a 100 OOO-fold ilution with medium. 
Zinc chloride (Nakarai Chemicals) was dissolved at a concentration of 
10 mM in 5 mM HCI. [%]cysteine and [%]dCTP were obtained 
from NEN research products (Boston, MA). Nick translation kit was 
obtained from Takara Biochemicals. The other chemicals used were 
analytical grade or DNA/RNA grade. 
2.2. Cell culture and MT induction 
Human Chang liver cells (ATCC CCL-13) were maintained in a 1:l 
(vol/vol) mixture of Dulbecco’s modified Eagle’s medium and Ham’s 
F12 medium containing 15 mM Hepes, 20 +g/ml of penicillin, 13.5 
fig/ml of ampicillin, 12 pg/ml of streptomycin and 10% (volhol) 
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fetal bovine serum. In experiments, the cells were placed into 9.6 em2 
and 55 cm2 dishes for protein and mRNA analyses respectively, and 
cultured for at least 24 h to semi-confluency. The semi-confluent cells 
were cultured with the above fresh medium containing various con- 
centrations of Zn2 +, Dex and EGF. 
2.3. MT-protein Ievel analyses 
For MT-protein analyses, 5 &i of [35S]cysteine was added with the 
inducers. After 18 h incubation, the cell extracts were carbox- 
ymethylated and analyzed by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis as described previously [171. MT levels were shown 
as percentages of [‘sS]cysteine-labeled MT to the sum of [“Slcysteine- 
labeled protein. 
2.4. MT-mRNA level analyses 
Cells were lysed with lysis buffer (4.0 M guanidine thiocyanate, 
0.12 M 2-mercaptoethanol, 0.025 M sodium acetate; pH 6.0) 9 h after 
induction. The cell lysates were overlaid to CsCl buffer (5.7 M CsCl, 
0.025 M sodium acetate; pH 6.0) and total RNA was spun down at 
174 000 x g for 20 h. Dot blot analyses using a dot blotter (Bio-Rad) 
were performed as described in [ 181. Total RNA (20 fig) was dotted on 
a GeneScreen Plus membrane (NEN research products) and hybridiz- 
ed with [35S]dCTP-labeled phMT-II3 probe, a cDNA of human MT- 
II*, kindly provided by M. Karin, labeled by nick translation. 
3. RESULTS 
We have studied the combined effects of two primary 
inducers on MT induction in Chang liver cells. Minor 
MT-protein induction by Dex alone occurred in a dose- 
dependent manner (Fig. la). Zn2+ also induced MT in 
a dose-dependent manner. MT-protein levels treated 
with both Dex and Zn2+ were greater than the sum of 
AT-protein levels treated with the same concentrations 
of each inducer separately, indicating that MT-protein 
was synergistically inducible by Dex and Zn2 + . 
Especially, marked synergism was seen at 80 PM Zn2+ .
Further marked induction of MT-protein was not seen 
with an increase in added Dex from 5 nM to 10 nM. 
Similariy, synergism of MT-protein induction by 
EGF and Dex was observed (Fig. lb). MT-protein was 
induced approximately 2-fold by either 5 ng/ml of EGF 
or 10 nM Dex in comparison to the control. MT-protein 
was induced approximately &fold by a combination of 
the same concentrations of Dex and EGF. Further MT- 
protein induction was seen with an increase in added 
Dex from 5 nM to 10 nM Dex, which differed from the 
synergism of Dex and Zn2 + . Little difference was seen 
among 1 ng/ml, 5 ng/ml and 10 ng/ml EGF (data for 
1 ng/ml are not shown). 
In contrast, the lines showing MT-protein levels 
treated with both Zr?+ and EGF were parallel to the 
line showing MT-protein levels treated with Zn’+ 
alone, indicating that Zn2 + and EGF induce MT- 
protein additively (Fig. lc). Similar additive induction 
by either 1 ng/ml, 5 ng/ml or 10 ng/ml EGF with Zn2+ 
was observed (data for 5 ng/ml are not shown). 
We compared the relationship between mRNA and 
protein levels of MT. MT-mRNA levels 9 h after induc- 
tion were not completely correlated with MT-protein 18 
h after induction (Fig. 2). Relatively high levels of MT- 
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Fig. 1. The combined effects of two primary inducers on MT induc- 
tion. Human Chang liver cells were treated with a, Dex and ZnZ+ (0, 
0 CM; 0, 40 pM; A, 80 FM); b, Dex and EGF (0,O ng/ml; l , 5 
ng/mi; A , 10 ng/ml); c, Zn2+ and EGF (0,O ng/ml; a, 5 nglml; 
A , 10 nglml). After an 18 h incubation, the cell extracts were car- 
boxymethylated and analyzed by SDS-15% poiyacrylamide gel elec- 
trophoresis. MT levels were shown as percentages of [3sS]cysteine- 
labeled MT to the sum of [?S]cysteine-labeled protein. 
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ther studies on posttranscriptional regulation are need- 
ed to dissolve the synergistic induction of MT-protein. 
We have not studied the effects of interferon, in- 
terleukin 1 or la,25_dihydroxyvitamin D3, which are 
reported to be primary endogenous inducers [4,5,8], 
because MT induction by these factors is not observed 
in Chang liver cells themselves [17]. Inflammatory 
stress increases tumor necrosis factor-a, interferon and 
interleukin 1 [20] and lesional stress and cold stress in- 
crease EGF [21]. Glucocorticoid hormones are well 
known to be increased by various stresses [14]. From 
these circumstances and our results, we propose a possi- 
ble mechanism in which a combined effect of minor in- 
creases in circulating glucocorticoid hormones and 
cytokines, the doses of which are not enough to induce 
marked induction of MT individually, may result in the 
marked MT induction in the liver by stress. 
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Fig. 2. mRNA and protein levels of MT induced by three inducers and 
their combinations. Chang liver cells were treated with 1, control; 2, 
10 nM Dex; 3, 80 pM Zn’+; 4, 10 ng/ml of EGF; 5, 10 nM Dex and 
80pM Zn2’; 6,80 pM Zn2+ and 10 ng/ml of EGF; 7,10 nM Dex and 
10 ng/ml of EGF. (a) mRNA levels 9 h after induction were analyzed 
by dot blot hybridizations. (b) Protein levels 18 h after induction were 
analyzed as shown in Fig. 1. (c) mRNA levels (open bars) and protein 
levels (dot bars) were shown by the relative concentrations to each 
control. 
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